SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Mar 27, 17:00
3414.75
-34.45 (-1%)
VOLUME 19,463
LIVE
NSE
Mar 27, 17:00
3415.40
-30.3 (-0.88%)
VOLUME 243,912

Stock Advice on Dr Reddys Laboratories

Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Post Q4 commentary important; like banks: P Lilladher 

12.35 pm | 26 Mar 2015 |  Source: CNBC-TV18

R Sreesankar of Prabhudas Lilladher says commentary post Q4 of FY15 will be important. He recommends investors to ‘accumulate’ pharma stocks thoug...

Here are some trading ideas from Chandan Taparia 

9.42 am | 25 Mar 2015 |  Source: CNBC-TV18

Watch the interview of Chandan Taparia of Anand Rathi Securities with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his readings and...

Prefer Dr Reddy’s Labs: Mayuresh Joshi 

4.51 pm | 24 Mar 2015 |  Source: CNBC-TV18

Mayuresh Joshi of Angel Broking is of the view that one may prefer Dr Reddy’s Labs....

Avoid pharma stocks: Sudarshan Sukhani 

4.43 pm | 23 Mar 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may avoid pharma space....

Buy Cipla, says Rahul Mohindar 

3.59 pm | 18 Mar 2015 |  Source: CNBC-TV18

Rahul Mohindar of viratechindia.com recommends buying Cipla as the stock may move towards Rs 780-775....

Advise investors to have 60% cyclical stocks: Citrus 

11.37 am | 18 Mar 2015 |  Source: CNBC-TV18

According to Sanjay Sinha of Citrus Advisors, portfolio should consist of 60 percent cyclical and 40 percent defensive stocks. Pharma and IT sectors s...

Go long in Dr Reddy's Labs: Amit Gupta 

11.24 am | 18 Mar 2015 |  Source: CNBC-TV18

Amit Gupta of ICICIdirect is of the view that one can go long in Dr Reddy's Laboratories and feels that Apollo Hospitals Enterprises may hit Rs 1540-1...

Here are some top trading ideas from Amit Gupta 

9.47 am | 18 Mar 2015 |  Source: CNBC-TV18

Watch the interview of Amit Gupta of ICICI Direct with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his readings and outlook on mar...

Use dips to buy quality stocks now; like Sun, L&T: Experts 

5.16 pm | 17 Mar 2015 |  Source: CNBC-TV18

Speaking to CNBC-TV18, Taher Badshah of Motilal Oswal AMC said such minor corrections should not worry traders and investors. “We have had four-five...

Expect 5-6% upside in Cipla, Dr Reddy's: Rahul Mohindar 

4.12 pm | 17 Mar 2015 |  Source: CNBC-TV18

Rahul Mohindar of viratechindia.com is of the view that one may see 5-6 percent upside in Cipla and Dr Reddy's Labs....

Buy Cipla, Dr Reddy's Labs; sell SBI: Rahul Mohindar 

2.48 pm | 17 Mar 2015 |  Source: CNBC-TV18

Rahul Mohindar of viratechindia.com recommends buying Cipla and Dr Reddy's Labs and advises selling SBI....

Here are top 10 stocks to focus on March 17 

8.44 am | 17 Mar 2015 |  Source: CNBC-TV18

Here are top 10 stocks to focus on March 17 - HCL Technologies, Jet Airways, Dr Reddys, Hindustan Unilever (HUL), HDFC Bank, Bank of Baroda, Amtek Aut...

Pharma will continue to outperform; avoid DLF: Sukhani 

5.07 pm | 16 Mar 2015 |  Source: CNBC-TV18

Sudarshan Sukhani also said that JSPL, which is currently trading around Rs 190 per share, is unlikely to sustain this rally....

Buy pharma stocks: Sudarshan Sukhani 

4.11 pm | 16 Mar 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying pharma stocks....

Prefer pharma stocks: Sudarshan Sukhani 

4.18 pm | 11 Mar 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may prefer pharma stocks....

Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.